Snowball logo
logo
2906

L&C Bio Co. Ltd

290650 KQ
54,700.00-2,100.00  (3.7%)
Estimate
Beta
1.492
Growth
Revenue, YoY
70.61%
Net income, YoY
708.71%
FCF, YoY
8.09%
Forecast
P/E (FWD)
25.5
EPS (FWD)
2,143.541
Dividends
Dividend yield
0.05%
Annual payout
25.00
Next ex. div date
December 29, 26
Div.rating
About the company
Ticker
290650
ISIN
KR7290650001
Country
South Korea
Sector (GICS)
Energy
L&C BIO Co.,LTD operates as a research and development company in tissue regeneration medicine. The company offers pharmaceuticals, human tissue, medical device, and cosmetics products. L&C BIO Co.,LTD was founded in 2011 and is headquartered in Seongnam-si, South Korea.

Frequently asked questions

What sector does L&C Bio Co. Ltd (290650) operate in?

L&C Bio Co. Ltd belongs to the Energy sector and operates in the Medical Devices industry.

What is L&C Bio Co. Ltd (290650) current stock price?

As of the latest data, L&C Bio Co. Ltd stock price is ₩54,700, with a previous close of ₩56,800. L&C Bio Co. Ltd lost -₩2,100 in the last trading session, representing a -3.7% loss.

What is L&C Bio Co. Ltd (290650) current market capitalization?

L&C Bio Co. Ltd market cap is approximately 1.35 trillion.

Does L&C Bio Co. Ltd (290650) pay dividends?

Yes. L&C Bio Co. Ltd pays annual dividends with an annualized yield of 0.05% and an estimated annual payout of ₩25 per share.

When is the next ex-dividend date for L&C Bio Co. Ltd (290650)?

The next ex-dividend date is scheduled for December 29, 2026.

What is L&C Bio Co. Ltd (290650) beta (volatility) score?

L&C Bio Co. Ltd has a beta of 1.492, suggesting it is more volatile than the market.